| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.15 |
0.006 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.007 |
| mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.008 |
| mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |